- Research works
- 37 ▼ 73% vs 2013–17
- Citations
- 1.1k 29.2 per fractional work
- Top-10% rate
- 5.6% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Pharmaleads (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Pharmaleads (France)?
By fractional works in all years, weighted toward what it does more of than the world: Neurological Disorders, Cancer Therapy, Calcitonin Gene-Related Peptide, Stress, Depression, Neuroprotection, Anxiety and Neuropeptides.
- Medicinal Chemistry
- Stromal Cells
- Nociception
- Immunosuppression
- Dendritic Spines
- Neuronal Plasticity
- Central Sensitization
- Synthesis
- Pain Management
- Antioxidant
- Astrocyte Function
- Drug Discovery
- Angiogenesis
- Calcium Signaling
- Receptors
- Immune Modulation
- Neuropeptides
- Neuroprotection
- Stress
- Cancer Therapy
- Neurological Disorders
- Calcitonin Gene-Related Peptide
- Depression
- Anxiety
- Treatment
- Opioid
- Inflammation
- Neurodegenerative Diseases
- Chronic Pain
- Tumor Microenvironment
- Neuroinflammation
- Chaperone
- Sigma-1 Receptor
- Toxicology
- Heterocycles
- Synaptic Plasticity
- Fibroblast Activation Protein
- Neuropathic Pain
- PET Imaging
- Wound Healing
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Neurological Disorders4▲ 15×6 topics
- Cancer Therapy3▲ 14×7 topics
- Calcitonin Gene-Related Peptide3▲ 101×2 topics
- Stress3▲ 19×3 topics
- Depression3▲ 9.8×3 topics
- Neuroprotection3▲ 19×6 topics
- Anxiety3▲ 19×2 topics
- Neuropeptides3▲ 64×2 topics
- Treatment3▲ 5.3×9 topics
- Immune Modulation2▲ 48×2 topics
- Opioid2▲ 110×1 topic
- Receptors2▲ 110×1 topic
- Inflammation2▲ 2.7×13 topics
- Calcium Signaling2▲ 38×2 topics
- Neurodegenerative Diseases2▲ 22×2 topics
- Angiogenesis2▲ 11×5 topics
- Chronic Pain2▲ 20×4 topics
- Drug Discovery2▲ 11×4 topics
- Tumor Microenvironment2▲ 13×5 topics
- Astrocyte Function2▲ 27×2 topics
- Neuroinflammation2▲ 16×2 topics
- Antioxidant2▲ 5.9×3 topics
- Chaperone2▲ 212×1 topic
- Pain Management2▲ 17×4 topics
- Sigma-1 Receptor2▲ 273×1 topic
- Synthesis2▲ 7.1×5 topics
- Toxicology2▲ 19×4 topics
- Central Sensitization1▲ 49×2 topics
- Heterocycles1▲ 20×4 topics
- Neuronal Plasticity1▲ 47×2 topics
- Synaptic Plasticity1▲ 12×3 topics
- Dendritic Spines1▲ 22×2 topics
- Fibroblast Activation Protein1▲ 66×1 topic
- Immunosuppression1▲ 29×1 topic
- Neuropathic Pain1▲ 45×1 topic
- Nociception1▲ 56×1 topic
- PET Imaging1▲ 17×2 topics
- Stromal Cells1▲ 38×2 topics
- Wound Healing1▲ 16×2 topics
- Medicinal Chemistry1▲ 8.4×5 topics
Which research topics does Pharmaleads (France) publish most on?
By volume in 2022–2025: Migraine and Headache Studies, Neuropeptides and Animal Physiology, Stress Responses and Cortisol and Neurological Disorders and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Migraine and Headache Studies Psychiatry and Mental health 0 works
- 2 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works
- 3 Stress Responses and Cortisol Behavioral Neuroscience 0 works
- 4 Neurological Disorders and Treatments Neurology 0 works
- 5 Neuroendocrine regulation and behavior Social Psychology 0 works
- 6 Neurological Complications and Syndromes Psychiatry and Mental health 0 works
- 7 Pain Mechanisms and Treatments Physiology 0 works
- 8 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works
- 9 Melanoma and MAPK Pathways Molecular Biology 0 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmaleads (France)'s research output changed?
Output in 2018–2022 was 73% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.